Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q4 2022 Earnings

15MarConfirmed

May 22

Aug 22

Nov 22

Q4 2022

-0.65

-0.63

-0.6

-0.58

Details

Expected EPS

-0.63

Actual EPS

-0.6

Surprise EPS

0.03

Surprise Percent

+4.76%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.6 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.